Found: 9
Select item for more details and to access through your institution.
Does the Country Make a Difference in Impulse Control Disorders? A Systematic Review.
- Published in:
- Movement Disorders Clinical Practice, 2021, v. 8, n. 1, p. 25, doi. 10.1002/mdc3.13128
- By:
- Publication type:
- Article
Non‐severe immunosuppression might be associated with a lower risk of moderate–severe acute respiratory distress syndrome in COVID‐19: A pilot study.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 4, p. 2243, doi. 10.1002/jmv.26656
- By:
- Publication type:
- Article
Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1399, doi. 10.3390/vaccines11091399
- By:
- Publication type:
- Article
Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 786, doi. 10.3390/vaccines11040786
- By:
- Publication type:
- Article
Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM Study.
- Published in:
- CNS Drugs, 2024, v. 38, n. 3, p. 231, doi. 10.1007/s40263-024-01066-3
- By:
- Publication type:
- Article
Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1288169
- By:
- Publication type:
- Article
COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1439393
- By:
- Publication type:
- Article
Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1454474
- By:
- Publication type:
- Article
Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy Adults.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 14, p. 7808, doi. 10.3390/ijms25147808
- By:
- Publication type:
- Article